Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis

British Heart Journal
|August 1, 1981
PubMed

Insights

Serious ventricular arrhythmias, including ventricular tachycardia, significantly predict sudden cardiac death in hypertrophic cardiomyopathy patients. Supraventricular arrhythmias did not show this association.

Area of Science:

  • Cardiology
  • Clinical Electrophysiology
  • Genetic Cardiomyopathies

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death in young individuals.
  • The association between specific arrhythmias and prognosis in HCM remains incompletely understood.
  • Risk stratification for sudden cardiac death (SCD) in HCM is crucial for timely intervention.

Purpose of the Study:

  • To investigate the relationship between arrhythmias detected by 72-hour ambulatory electrocardiographic monitoring and subsequent prognosis in patients with hypertrophic cardiomyopathy.
  • To identify specific arrhythmia types that are predictive of sudden cardiac death in this patient population.

Main Methods:

  • Eighty-six unselected patients with hypertrophic cardiomyopathy underwent 72-hour ambulatory electrocardiographic monitoring.
  • Patients were followed for a mean of 2.6 years to ascertain outcomes, including sudden death.
  • Arrhythmia data, including supraventricular tachycardia and ventricular tachycardia, were analyzed in relation to mortality.

Main Results:

  • Seven patients died suddenly during the follow-up period.
  • Ventricular tachycardia and multiform/paired ventricular extrasystoles were significantly associated with sudden death (p<0.05).
  • Supraventricular arrhythmias were not significantly associated with sudden death; however, patients who died were older and more symptomatic.

Conclusions:

  • Ventricular arrhythmias, particularly ventricular tachycardia, are significant predictors of sudden cardiac death in hypertrophic cardiomyopathy.
  • These findings support the need for careful assessment and potential treatment of ventricular arrhythmias in HCM patients.
  • Further research into risk stratification and therapeutic strategies for HCM patients with serious ventricular arrhythmias is warranted.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...